Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Rabobank New Zealand announces appointment

Rabobank New Zealand announces appointment of new general manager Country Banking

Rabobank New Zealand has announced the appointment of Hayley Moynihan to the new role of general manager Country Banking.

Subject to regulatory approval from the Reserve Bank of New Zealand, Ms Moynihan will commence in the role from July 2, 2015.

Reporting to Rabobank New Zealand chief executive officer Ben Russell, the general manager Country Banking will be responsible for leadership of Rabobank’s rural banking business throughout New Zealand.

Mr Russell said Ms Moynihan – who has worked for Rabobank New Zealand for the past 10 years in its Food & Agribusiness Research & Advisory division, most recently as Director of Dairy Research, New Zealand and Asia – was a “highly-credentialed career agri banker, who has a deep understanding of New Zealand’s agricultural industries and its farm businesses as well as the wider global market”.

“Hayley has already made a significant contribution to Rabobank New Zealand and our clients through her highly-respected insights on the dairy industry and the wider food sector in New Zealand and internationally. She will bring significant experience, knowledge and an innovative approach to our core rural banking franchise,” Mr Russell said.

Rabobank’s Country Banking franchise primarily services farming businesses across all of New Zealand’s agricultural sectors, together with commercial businesses in the food and agribusiness sector beyond the farmgate. Rabobank has a 17 per cent share of the New Zealand agricultural debt market, and has consistently grown this share over the past decade.

Before joining Rabobank’s research team in New Zealand, Ms Moynihan led Rabobank’s London food and agribusiness corporate credit team.

She previously spent nine years as a rural and retail banker in New Zealand with Westpac and Trustbank.

Ms Moynihan said after 10 years focused on agricultural research and analysis, she was looking forward to returning to agricultural banking and working more closely with Rabobank’s New Zealand clients.

“The current challenges facing dairy notwithstanding, New Zealand has one of the world’s most dynamic and successful agricultural industries, with a very positive and exciting long-term outlook in the global market,” she said. “And I’m very much looking forward to taking an active role helping to lead Rabobank’s work supporting our New Zealand clients as they take advantage of this future growth potential.”

ENDS


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Marine And Freshwater Reports: EDS Calls For Urgent Action On Marine Management

“There are some big issues to address. These include many marine species and habitats that are in serious trouble. Of the sample investigated, the report finds that 22% of marine mammals, 90% of seabirds and 80% of shorebirds are threatened with or actually at risk of extinction..." More>>

ALSO:

$7.5 Billion Surplus: Government Accounts "Show Strong Economy"

“The surplus and low levels of debt show the economy is in good shape. This allows the Government to spend more on infrastructure and make record investments in health and education,” Grant Robertson says. More>>

ALSO:

New OIO Application Trumps Judicial Review: OceanaGold Cleared To Buy Land For Waihi Tailings Expansion

In a surprise turnaround, the government has given OceanaGold a greenlight to buy land to expand its Waihi mine after the application was previously turned down by Land Information Minister Eugenie Sage. More>>

ALSO:

Christchurch Rebuild: Fletcher Sued For $7.5m Over Justice Precinct

Fletcher Building is being sued for $7.5 million by utilities contractor Electrix, one of the subcontractors on the Christchurch Justice and Emergency Services Precinct. More>>

Three New Drugs: PHARMAC Signs Bundle Deal For More Cancer Medicines

420 New Zealanders with lung cancer, breast cancer, multiple sclerosis and respiratory disease will benefit each year from a bundle deal PHARMAC has finalised with a medicine supplier. More>>

ALSO: